Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics

Консенсусный документ экспертов: консенсусное заявление Международной научной ассоциации по пробиотикам и пребиотикам (ISAPP) об определении и области применения пребиотиков
Glenn R. Gibson, Kelly Scott Swanson, Karen P. Scott, Raylene A. Reimer, Catherine Stanton, Robert W. Hutkins, Mary Ellen Sanders, Susan L. Prescott, Seppo Salminen, Patrice D. Cani, Kristin Verbeke, Gregor Reid
2017-06-14

ISAPP consensus statementgut microbiotahealth benefitsprebioticsselective microbiota utilization
With the continued interest in the role of the gut microbiota in health, attention has now turned to how to harness the microbiota for the benefit of the host. This Consensus Statement outlines the definition and scope of the term 'prebiotic' as determined by an expert panel convened by the International Scientific Association for Probiotics and Prebiotics in December 2016. In December 2016, a panel of experts in microbiology, nutrition and clinical research was convened by the International Scientific Association for Probiotics and Prebiotics to review the definition and scope of prebiotics. Consistent with the original embodiment of prebiotics, but aware of the latest scientific and clinical developments, the panel updated the definition of a prebiotic: a substrate that is selectively utilized by host microorganisms conferring a health benefit. This definition expands the concept of prebiotics to possibly include non-carbohydrate substances, applications to body sites other than the gastrointestinal tract, and diverse categories other than food. The requirement for selective microbiota-mediated mechanisms was retained. Beneficial health effects must be documented for a substance to be considered a prebiotic. The consensus definition applies also to prebiotics for use by animals, in which microbiota-focused strategies to maintain health and prevent disease is as relevant as for humans. Ultimately, the goal of this Consensus Statement is to engender appropriate use of the term 'prebiotic' by relevant stakeholders so that consistency and clarity can be achieved in research reports, product marketing and regulatory oversight of the category. To this end, we have reviewed several aspects of prebiotic science including its development, health benefits and legislation.
1
An expert ISAPP panel updated the prebiotic definition to “a substrate that is selectively utilized by host microorganisms conferring a health benefit.”
2
The consensus definition applies to prebiotics intended for animals as well as humans.
3
The expanded concept may include non-carbohydrate substances, body sites beyond the gastrointestinal tract, and applications beyond foods.
4
The revised definition retains selective microbiota-mediated utilization and requires documented beneficial health effects for prebiotic classification.
5
The statement aims to standardize prebiotic terminology across scientific reporting, product marketing, and regulatory oversight.

Prebiotics (substances selectively utilized by host microorganisms)

the definition, scope, selective microbiota-mediated utilization, and health-benefit criteria of prebiotics

Publication Details
Publication Date
2017-06-14
Journal
Publisher
ISSN
Cited by
5595
Access Type
Author Information
Authors
Glenn R. Gibson
Kelly Scott Swanson
Karen P. Scott
Raylene A. Reimer
Catherine Stanton
Robert W. Hutkins
Mary Ellen Sanders
Susan L. Prescott
Seppo Salminen
Patrice D. Cani
Kristin Verbeke
Gregor Reid
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%